| Gene symbol | CD44 | Synonyms | CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL, HUTCH-1, HUTCH-I, Hermes-1, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p13 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | CD44 molecule (IN blood group) | ||||
| GTO ID | GTC2192 |
| Trial ID | NCT04097301 |
| Disease | Acute Myeloid Leukemia | Multiple Myeloma |
| Altered gene | CD44 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MLM-CAR44.1 T-cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Terminated |
| Title | Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma |
| Year | 2019 |
| Country | Italy |
| Company sponsor | AGC Biologics S.p.A. |
| Other ID(s) | EURE-CART-1|2018-000813-19 |
| Cohort 1 | |||||||||||
|
|||||||||||